> Detailanzeige

Saiman, Lisa; Siegel, Jane D.; LiPuma, John J.; Brown, Rebekah F.; Bryson, Elizabeth A.; Chambers, Mary Jo; Downer, Veronica S.; Fliege, Jill; Hazle, Leslie A.; Jain, Manu; Marshall, Bruce C.; O’Malley, Catherine; Pattee, Suzanne R.; Potter-Bynoe, Gail; Reid, Siobhan; Robinson, Karen A.; Sabadosa, Kathryn A.; Schmidt, H. Joel; Tullis, Elizabeth; Webber, Jennifer; Weber, David J.

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
  • Beteiligte: Saiman, Lisa; Siegel, Jane D.; LiPuma, John J.; Brown, Rebekah F.; Bryson, Elizabeth A.; Chambers, Mary Jo; Downer, Veronica S.; Fliege, Jill; Hazle, Leslie A.; Jain, Manu; Marshall, Bruce C.; O’Malley, Catherine; Pattee, Suzanne R.; Potter-Bynoe, Gail; Reid, Siobhan; Robinson, Karen A.; Sabadosa, Kathryn A.; Schmidt, H. Joel; Tullis, Elizabeth; Webber, Jennifer; Weber, David J.
  • Erschienen: Cambridge University Press (CUP), 2014
  • Erschienen in: Infection Control & Hospital Epidemiology, 35 (2014) S1, Seite s1-s67
  • Sprache: Englisch
  • DOI: 10.1086/676882
  • ISSN: 0899-823X; 1559-6834
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline for CF. During the past decade, new knowledge and new challenges provided the following rationale to develop updated IP&C strategies for this unique population:1.The need to integrate relevant recommendations from evidence-based guidelines published since 2003 into IP&C practices for CF. These included guidelines from the Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC), the World Health Organization (WHO), and key professional societies, including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). During the past decade, new evidence has led to a renewed emphasis on source containment of potential pathogens and the role played by the contaminated healthcare environment in the transmission of infectious agents. Furthermore, an increased understanding of the importance of the application of implementation science, monitoring adherence, and feedback principles has been shown to increase the effectiveness of IP&C guideline recommendations.2.Experience with emerging pathogens in the non-CF population has expanded our understanding of droplet transmission of respiratory pathogens and can inform IP&C strategies for CF. These pathogens include severe acute respiratory syndrome coronavirus and the 2009 influenza A H1N1. Lessons learned about preventing transmission of methicillin-resistantStaphylococcus aureus(MRSA) and multidrug-resistant gram-negative pathogens in non-CF patient populations also can inform IP&C strategies for CF.